Year: 2016
Type: review
Abstract: Many genetic lesions have been identified in lung cancers. The findings shed light on molecular pathogenesis and have led to the definition of abnormalities that can be targeted by therapeutic agents that occasionally elicit dramatic responses.
Source: New England Journal of Medicine
Authors: Charles Swanton, Ramaswamy Govindan
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Cancer Research UK, Novo Nordisk Fonden
Awards: G182428912, G3486387481
OpenAlex ID: W2364794827
